REQUEST A DEMO
Total
USD $0.00
Search more companies

Bsv Bioscience Philippines Inc. (Philippines)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers
Full name: Bsv Bioscience Philippines Inc. Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Bsv Bioscience Philippines Inc. is based in Philippines, with the head office in Pasig City. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The company was established on February 11, 2016. From the latest financial highlights, Bsv Bioscience Philippines Inc. reported a net sales revenue increase of 32.03% in 2025. Its total assets grew by 35.27% over the same period. In 2025, Bsv Bioscience Philippines Inc.’s net profit margin decreased by 5.68%.

Headquarters
Unit 1002, 10Th Floor Exquadra Tower No. 1 Jade Drive, Ortigas Center Barangay San Antonio
Pasig City; Metro Manila;

Contact Details: Purchase the Bsv Bioscience Philippines Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Bsv Bioscience Philippines Inc. report to view the information.
Incorporation Date:
February 11, 2016
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bsv Bioscience Philippines Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
32.03%
Total Operating Revenue
32.03%
Net Profit/Loss for the Period
1.78%
Total Assets
35.27%
Total Equity
45.12%
Net Profit Margin
-5.68%
Return on Equity (ROE)
-13.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?